[Phakic intraocular lenses for high-grade myopia]

Lazo E, García Martí S, Alfie V, Navarro E, Bardach A, Pichon Riviere A, Augustovski F Alcaraz A, Ciapponi A
Record ID 32018004434
Original Title: Lentes intraoculares fáquicos en miopía alta
Authors' recommendations: Moderate-quality evidence shows that phakic intraocular lenses probably result in a lower net benefit when compared with excimer laser refractive surgery in high-grade myopia. Intraocular lenses are associated with similar results in visual acuity improvement; they are more likely to achieve a spherical equivalence within +/- 1.0 diopter of refractive target and less likely to lose one or more lines of improved corrected visual acuity with glasses. However, these results cannot be extrapolated beyond 12 months after surgery due to lack of evidence at longer term. The use of this technology when compared with laser refractive surgery was not associated to a higher number of postoperative complications. However, a longer follow-up period is necessary to determine safety concerns at long term. One clinical practice guideline suggests that the use of phakic intraocular lenses may be considered for high-grade myopia patients who are willing to reduce their dependence on glasses or contact lenses. Except for the United Kingdom, where coverage is provided after performing an audit, no coverage policies have been found on the use of phakic intraocular lenses for refractive errors. In Argentina, this technology is not included in the Mandatory Medical Plan; it is not listed in the Unique Reimbursement System of the Superintendence of Health Services either. No economic evaluations on the use of phakic intraocular lenses for high-grade myopia have been found.
Project Status: Completed
Year Published: 2022
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Argentina
MeSH Terms
  • Myopia
  • Lens Implantation, Intraocular
  • Lenses, Intraocular
  • Phakic Intraocular Lenses
Organisation Name: Institute for Clinical Effectiveness and Health Policy
Contact Address: Dr. Emilio Ravignani 2024, Buenos Aires - Argentina, C1414 CABA
Contact Name: info@iecs.org.ar
Contact Email: info@iecs.org.ar
Copyright: Institute for Clinical Effectiveness and Health Policy (IECS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.